Cellebrite DI Ltd. (NASDAQ:CLBT) Position Reduced by Phoenix Financial Ltd.

Phoenix Financial Ltd. lowered its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 37.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,413,424 shares of the company's stock after selling 853,573 shares during the quarter. Phoenix Financial Ltd. owned about 0.69% of Cellebrite DI worth $31,138,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLBT. Juncture Wealth Strategies LLC grew its stake in Cellebrite DI by 0.8% during the fourth quarter. Juncture Wealth Strategies LLC now owns 60,003 shares of the company's stock worth $1,322,000 after buying an additional 505 shares during the period. Strategic Advisors LLC raised its holdings in shares of Cellebrite DI by 3.4% during the 4th quarter. Strategic Advisors LLC now owns 29,082 shares of the company's stock valued at $641,000 after buying an additional 950 shares during the period. Steward Partners Investment Advisory LLC boosted its stake in shares of Cellebrite DI by 12.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 13,590 shares of the company's stock valued at $299,000 after purchasing an additional 1,463 shares during the period. Quarry LP acquired a new position in Cellebrite DI in the 3rd quarter worth $27,000. Finally, Tower View Wealth Management LLC boosted its position in Cellebrite DI by 1.3% in the 4th quarter. Tower View Wealth Management LLC now owns 132,307 shares of the company's stock valued at $2,915,000 after buying an additional 1,660 shares during the last quarter. Institutional investors and hedge funds own 45.88% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several research firms recently commented on CLBT. Lake Street Capital boosted their price target on Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday, February 14th. JPMorgan Chase & Co. lifted their target price on Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 11th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $28.00 price objective on shares of Cellebrite DI in a research report on Wednesday, April 2nd. Seven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $23.43.

Cellebrite DI Stock Performance

Shares of NASDAQ:CLBT traded up $0.15 on Tuesday, hitting $19.20. The company's stock had a trading volume of 207,316 shares, compared to its average volume of 1,396,801. The company has a market capitalization of $4.60 billion, a price-to-earnings ratio of -13.81, a price-to-earnings-growth ratio of 4.27 and a beta of 1.44. The stock's 50-day moving average is $19.48 and its two-hundred day moving average is $20.03. Cellebrite DI Ltd. has a 12 month low of $10.25 and a 12 month high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. Equities analysts expect that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.